AARTHI RAMESHKUMAR: Open Payments
NPI 1841961612 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,095 in 188 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,555 · 2025 $3,095
Food & beverage: $3,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 77 | $762 |
| UCB, Inc. | 16 | $524 |
| Amgen Inc. | 26 | $351 |
| PFIZER INC. | 11 | $205 |
| Radius Health, Inc. | 7 | $174 |
| AstraZeneca Pharmaceuticals LP | 9 | $167 |
| Janssen Biotech, Inc. | 8 | $160 |
| E.R. Squibb & Sons, L.L.C. | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Mallinckrodt Hospital Products Inc. | 4 | $93 |
Products named: Bimzelx, RINVOQ, SKYRIZI, XELJANZ, Tymlos, TREMFYA, KRYSTEXXA, UPLIZNA.
Industry payments across AZ — which companies pay providers there.
